Assessing PSA Response in Low Dose Ketoconazole in Hormone Refractory Prostate Cancer Patients Who Have Failed at Least One Prior Systemic Chemotherapy Regimen.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ketoconazole (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 30 Mar 2017 Biomarkers information updated
- 10 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Dec 2013 Planned end date changed from 1 Jun 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov.